stachydrine has been researched along with Osteolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, B; He, J; Hong, J; Hu, B; Jiang, G; Li, S; Meng, J; Wang, W; Wang, Y; Yan, S; Yan, W; Zhang, W; Zhou, C | 1 |
1 other study(ies) available for stachydrine and Osteolysis
Article | Year |
---|---|
Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
Topics: Actins; Active Transport, Cell Nucleus; Animals; Cell Nucleus; Cell Survival; Cells, Cultured; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis; Proline; Proto-Oncogene Proteins c-akt; RANK Ligand; Signal Transduction; T-Lymphocytes; Tomography, X-Ray Computed | 2019 |